Clinical Efficacy of Coded Herbal Medicine Eczegone for the Management of Eczema (Nar-e-Farsi)

Authors

  • Muhammad Amjad Chishti Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University Karachi, Pakistan.
  • Ejaz Mohi-Ud-Din Department of Surgery and Allied Sciences, Faculty of Eastern Medicine, Hamdard University Karachi, Pakistan.
  • Sultan Ayaz Department of Eastern Medicine Government College University Faisalabad, Faisalabad, Pakistan.
  • Saeed Ahmad University College of Agriculture, University of Sargodha, Pakistan.
  • Muhammad Ahmed Chishti Al-Rasheed Chishti, Darulshifa Head, Malkani, Liaquatpur, Pakistan.
  • Naveed Ahmed Department of Pharmacy, University of Poonch, Rawlakot, Pakistan.

Keywords:

Eczema, Sensitivity, Papules, Plaques, Discharge

Abstract

Background: Eczema is a frequent name for a condition called atopic dermatitis (AD) an inflammatory, chronic, intensely itchy, and reversing skin disease. AD is categorized as a disease of the outer skin layer barrier. Immunoglobulin E-facilitated sensitivity to food and environmental allergens is advancing. Gene-environment interactions are becoming more complex the commonness of AD. The three standard stages of AD are childhood, adolescence, and adulthood. The signs and symptoms of AD vary greatly. AD can be present with erythroderma, erythematous papules, intense itching, plaques and papules with lichenification and serous discharge in the patient.

Objectives: To establish and evaluate scientific and clinical evidence of herbal/eastern formulation and find out the clinical safety and efficacy and to measure the clinical response of herbal formulation in the patients of Eczema.

Methodology: This study involved 190 individuals, of whom 95 received Dermovate ointment and tablets and 95 received Benadryl tablets. After reviewing the inclusion as well as exclusion criteria and acquiring written informed consent, patients were chosen.

Results: Compared to the Benadryl pill and Dermovate ointment groups, the Eczegone ointment and tablet group significantly improved AD-related skin symptoms. The Eczegone pill and ointment work effectively and are well tolerated. Pair sample t-test analysis was utilized to determine the outcomes. The calculated probability value is 0.05.

Conclusion: The test group (Eczegone ointment and tablet) performed noticeably better than the Dermovate and Benadryl tablet groups.

Downloads

Published

2024-01-04

Issue

Vol. 1 No. 3 (2023): Volume 1 (3) 2023

Section

Articles